{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:05:09Z","timestamp":1793927109968,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018780","name":"Servicio Andaluz de Salud","doi-asserted-by":"publisher","award":["PI4400"],"award-info":[{"award-number":["PI4400"]}],"id":[{"id":"10.13039\/501100018780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI021155"],"award-info":[{"award-number":["PI021155"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-alcoholic fatty liver disease is associated with obesity. A subclinical inflammation state, endothelial dysfunction, and parameters related to metabolic syndrome (MetS), have been documented in children with obesity. We aimed to determine the changes that occur in liver enzymes levels in response to the standard treatment of childhood obesity, also assessing any associations with liver enzyme levels, leptin, and markers of insulin resistance (IR), inflammation, and parameters related to MetS in prepubertal children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We carried out a longitudinal study in prepubertal children (aged 6\u20139\u00a0years) of both sexes with obesity; a total of 63 participants were recruited. Liver enzymes, C-reactive protein (CRP), interleukin-6, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), soluble intercellular adhesion molecule-1 (sICAM-1), leptin, homeostasis model assessment for IR (HOMA-IR), and parameters related to MetS were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After standard treatment for 9\u00a0months, children who lowered their standardised body mass index (SDS-BMI) had significantly lower systolic blood pressure (<jats:italic>p<\/jats:italic>\u2009=\u20090.0242), diastolic blood pressure (<jats:italic>p<\/jats:italic>\u2009=\u20090.0002), HOMA-IR (<jats:italic>p<\/jats:italic>\u2009=\u20090.0061), and levels of alanine aminotransferase (ALT) (<jats:italic>p<\/jats:italic>\u2009=\u20090.0048), CRP (<jats:italic>p<\/jats:italic>\u2009=\u20090.0001), sICAM-1 (<jats:italic>p<\/jats:italic>\u2009=\u20090.0460), and IL-6 (<jats:italic>p<\/jats:italic>\u2009=\u20090.0438). There was a significant association between the changes that occur with treatment, in the ALT levels, and changes in leptin (<jats:italic>p<\/jats:italic>\u2009=\u20090.0096), inflammation biomarkers [CRP (<jats:italic>p<\/jats:italic>\u2009=\u20090.0061), IL-6 (<jats:italic>p<\/jats:italic>\u2009=\u20090.0337), NLR (<jats:italic>p<\/jats:italic>\u2009=\u20090.0458), PLR (<jats:italic>p<\/jats:italic>\u2009=\u20090.0134)], and HOMA-IR (<jats:italic>p<\/jats:italic>\u2009=\u20090.0322).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results showed that a decrease in ALT levels after the standard treatment for 9\u00a0months was associated with favourable changes in IR markers (HOMA-IR) and inflammation (IL-6, CRP, NLR, and PLR).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-023-01434-7","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:14:21Z","timestamp":1679861661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Changes in liver enzymes are associated with changes in insulin resistance, inflammatory biomarkers and leptin in prepubertal children with obesity"],"prefix":"10.1186","volume":"49","author":[{"given":"Rosario","family":"Valle-Martos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Jim\u00e9nez-Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Martos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-9033","authenticated-orcid":false,"given":"Miguel","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents \u2013 an IDF consensus report. Pediatr Diabetes. 2007;8:299\u2013306. https:\/\/doi.org\/10.1111\/j.1399-5448.2007.00271.x.","journal-title":"Pediatr Diabetes."},{"key":"1434_CR2","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1161\/01.CIR.0000089190.95415.9F","volume":"108","author":"PE Szimiko","year":"2003","unstructured":"Szimiko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation. 2003;108:1917\u201323. https:\/\/doi.org\/10.1161\/01.CIR.0000089190.95415.9F.","journal-title":"Circulation"},{"key":"1434_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/meta.2002.31319","volume":"51","author":"M Valle","year":"2002","unstructured":"Valle M, Gasc\u00f3n F, Martos R, Ruz FJ, Bermudo F, Morales R, Ca\u00f1ete R. Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasting insulin levels. Metabolism. 2002;51:423\u20138. https:\/\/doi.org\/10.1053\/meta.2002.31319.","journal-title":"Metabolism"},{"key":"1434_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/oby.2003.15","volume":"11","author":"S Shea","year":"2003","unstructured":"Shea S, Aymong E, Zybert P, Shamoon H, Tracy RP, Deckelbaum RJ, et al. Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res. 2003;11:95\u2013103. https:\/\/doi.org\/10.1038\/oby.2003.15.","journal-title":"Obes Res"},{"key":"1434_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.metabol.2016.08.001","volume":"66","author":"SA Polyzos","year":"2017","unstructured":"Polyzos SA, Bugianesi E, Kountouras J, Mantzoros CS. Nonalcoholic fatty liver disease: updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-\u03b3 agonists. Metabolism. 2017;66:64\u20138. https:\/\/doi.org\/10.1016\/j.metabol.2016.08.001.","journal-title":"Metabolism"},{"key":"1434_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274\u201385. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04724.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1434_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1586\/17474124.2014.903798","volume":"8","author":"MV Machado","year":"2014","unstructured":"Machado MV, Cortez-Pinto H. Management of fatty liver disease with the metabolic syndrome. Expert Rev Gastroenterol Hepatol. 2014;8(5):487\u2013500. https:\/\/doi.org\/10.1586\/17474124.2014.903798.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"1434_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40618-016-0576-8","volume":"40","author":"P Di Bonito","year":"2017","unstructured":"Di Bonito P, Pacifico L, Chiesa C, Valerio G, Miraglia Del Giudice E, Maffeis C, et al. Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight\/obesity. J Endocrinol Invest. 2017;40(4):409\u201316. https:\/\/doi.org\/10.1007\/s40618-016-0576-8.","journal-title":"J Endocrinol Invest"},{"key":"1434_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology. 2011;140:124\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2010.09.038.","journal-title":"Gastroenterology"},{"issue":"10","key":"1434_CR10","doi-asserted-by":"publisher","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","volume":"10","author":"EL Andeerson","year":"2015","unstructured":"Andeerson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One. 2015;10(10):e0140908. https:\/\/doi.org\/10.1371\/journal.pone.0140908.","journal-title":"PLoS One."},{"key":"1434_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004.","journal-title":"J Hepatol."},{"key":"1434_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3803\/EnM.2018.33.1.33","volume":"33","author":"C Boutari","year":"2018","unstructured":"Boutari C, Perakakis N, Mantzoros CS. Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease. Endocrinol Metab (Seoul). 2018;33:33\u201343. https:\/\/doi.org\/10.3803\/EnM.2018.33.1.33.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1434_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3350\/cmh.2018.0011","volume":"24","author":"L Rotundo","year":"2018","unstructured":"Rotundo L, Persaud A, Feurdean M, Ahlawat S, Kim HS. The Association of leptin with severity of non-alcoholic fatty liver disease: a population-based study. Cli n Mol Hepatol. 2018;24:392\u2013401. https:\/\/doi.org\/10.3350\/cmh.2018.0011.","journal-title":"Cli n Mol Hepatol"},{"issue":"3","key":"1434_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/apa.15469","volume":"110","author":"C Hartman","year":"2021","unstructured":"Hartman C, Rennert HS, Rennert G, Elenberg Y, Zuckerman E. Prevalence of elevated liver enzymes and comorbidities in children and adolescents with overweight and obesity. Acta Paediatr. 2021;110(3):985\u201392. https:\/\/doi.org\/10.1111\/apa.15469.","journal-title":"Acta Paediatr"},{"key":"1434_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/ATVBAHA.112.300075","volume":"33","author":"SA Porter","year":"2013","unstructured":"Porter SA, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Fox CS. Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2013;33:139\u201346. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300075.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1434_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"MB Vos","year":"2017","unstructured":"Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319\u201334. https:\/\/doi.org\/10.1097\/MPG.0000000000001482.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"1434_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/1753-0407.12221","volume":"7","author":"M Klein","year":"2015","unstructured":"Klein M, Iazzettii L, Speiser P, Carey D, Shelov S, Accacha S, et al. Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth. J Diabetes. 2015;7(5):649\u201356. https:\/\/doi.org\/10.1111\/1753-0407.12221.","journal-title":"J Diabetes"},{"key":"1434_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/met.2010.0086","volume":"9","author":"DA Patel","year":"2011","unstructured":"Patel DA, Srinivasan SR, Chen W, Berenson GS. Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study. Metab Syndr Relat Disord. 2011;9:211\u20136. https:\/\/doi.org\/10.1089\/met.2010.0086.","journal-title":"Metab Syndr Relat Disord"},{"key":"1434_CR19","doi-asserted-by":"publisher","unstructured":"Duchnowicz P, Ziobro A, Rapacka E, Koter-Michalak M, Bukowska B. Changes in Cholinesterase Activity in Blood of Adolescent with Metabolic Syndrome after Supplementation with Extract from Aronia melanocarpa. Biomed Res Int. 2018:5670145. https:\/\/doi.org\/10.1155\/2018\/5670145","DOI":"10.1155\/2018\/5670145"},{"key":"1434_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cld.2015.10.008","volume":"20","author":"SA Harrison","year":"2016","unstructured":"Hannah WN Jr, Harrison SA. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2016;20:339\u201350. https:\/\/doi.org\/10.1016\/j.cld.2015.10.008.","journal-title":"Clin Liver Dis"},{"key":"1434_CR21","doi-asserted-by":"publisher","first-page":"629346","DOI":"10.3389\/fped.2021.629346","volume":"9","author":"R Valle-Martos","year":"2021","unstructured":"Valle-Martos R, Valle M, Martos R, Ca\u00f1ete R, Jim\u00e9nez-Reina L, Ca\u00f1ete MD. Liver Enzymes Correlate With Metabolic Syndrome. Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity Front Pediatr. 2021;9:629346. https:\/\/doi.org\/10.3389\/fped.2021.629346.","journal-title":"Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity Front Pediatr."},{"key":"1434_CR22","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240\u20133. https:\/\/doi.org\/10.1136\/bmj.320.7244.1240.","journal-title":"BMJ."},{"key":"1434_CR23","unstructured":"Moreno Aznar LA, Olivera JE. Obesidad. En: Protocolos diagn\u00f3sticos y terap\u00e9uticos en Pediatr\u00eda. Tomo 5. Gastroenterolog\u00eda, Hepatolog\u00eda y Nutrici\u00f3n. 2002 Madrid. AEP. P.353\u2013360."},{"key":"1434_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1157\/13099693","volume":"66","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Alonso M, G\u00f3mez L, Mart\u00ednez C, Sierra C. Childhood obesity: recommendations of the Nutrition Committee of the Spanish Association of Pediatrics. Part II: diagnosis, comorbidities, treatment (in Spanish). An Pediatr (Barc). 2007;66:294\u2013304. https:\/\/doi.org\/10.1157\/13099693.","journal-title":"An Pediatr (Barc)."},{"key":"1434_CR25","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ijo.2014.130","volume":"38","author":"W Ahrens","year":"2014","unstructured":"Ahrens W, Moreno LA, M\u00e5rild S, Moln\u00e1r D, Siani A, De Henauw S, et al. Metabolic syndrome in young children: definitions and results of the IDEFICS study. Int J Obes. 2014;38:S4-14. https:\/\/doi.org\/10.1038\/ijo.2014.130.","journal-title":"Int J Obes"},{"key":"1434_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3132\/dvdr.2007.003","volume":"4","author":"C Day","year":"2007","unstructured":"Day C. Metabolic syndrome, or what you will: definitions and epidemiology. Diab Vasc Dis Res. 2007;4:32\u20138. https:\/\/doi.org\/10.3132\/dvdr.2007.003.","journal-title":"Diab Vasc Dis Res"},{"key":"1434_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/MPG.0000000000002523","volume":"70","author":"V Cuzmar","year":"2020","unstructured":"Cuzmar V, Alberti G, Uauy R, Pereira A, Garc\u00eda C, De Barbieri F, et al. Early Obesity: Risk Factor for Fatty Liver Disease. J Pediatr Gastroenterol Nutr. 2020;70:93\u20138. https:\/\/doi.org\/10.1097\/MPG.0000000000002523.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1434_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","volume":"207","author":"EL Yu","year":"2019","unstructured":"Yu EL, Golshan S, Harlow KE, Angeles JE, Durelle J, Goyal NP, et al. Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. J Pediatr. 2019;207:64\u201370. https:\/\/doi.org\/10.1016\/j.jpeds.2018.11.021.","journal-title":"J Pediatr"},{"key":"1434_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamapediatrics.2014.2702","volume":"169","author":"V Nobili","year":"2015","unstructured":"Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, Raponi M, et al. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr. 2015;169:170\u20136. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.2702.","journal-title":"JAMA Pediatr"},{"issue":"11","key":"1434_CR30","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s40279-016-0537-6","volume":"46","author":"L Stoner","year":"2016","unstructured":"Stoner L, Rowlands D, Morrison A, Credeur D, Hamlin M, Gaffney K, et al. Efficacy of Exercise Intervention for Weight Loss in Overweight and Obese Adolescents: Meta-Analysis and Implications. Sports Med. 2016;46(11):1737\u201351. https:\/\/doi.org\/10.1007\/s40279-016-0537-6.","journal-title":"Sports Med"},{"issue":"6","key":"1434_CR31","doi-asserted-by":"publisher","first-page":"CD012651","DOI":"10.1002\/14651858.CD012651","volume":"6","author":"E Mead","year":"2017","unstructured":"Mead E, Brown T, Rees K, Azevedo LB, Whittaker V, Jones D, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev. 2017;6(6):CD012651. https:\/\/doi.org\/10.1002\/14651858.CD012651.","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"1434_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12966-016-0424-4","volume":"13","author":"J Peplies","year":"2016","unstructured":"Peplies J, B\u00f6rnhorst C, G\u00fcnther K, Fraterman A, Russo P, Veidebaum T, et al. IDEFICS consortium. Longitudinal associations of lifestyle factors and weight status with insulin resistance (HOMA-IR) in preadolescent children: the large prospective cohort study IDEFICS. Int J Behav Nutr Phys Act. 2016;13(1):97. https:\/\/doi.org\/10.1186\/s12966-016-0424-4.","journal-title":"Int J Behav Nutr Phys Act."},{"issue":"4","key":"1434_CR33","doi-asserted-by":"publisher","first-page":"e12601","DOI":"10.1111\/ijpo.12601","volume":"15","author":"F Koutny","year":"2020","unstructured":"Koutny F, Weghuber D, Bollow E, Greber-Platzer S, Hartmann K, K\u00f6rner A, et al. Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. Analysis of the APV initiative. Pediatr Obes. 2020;15(4):e12601. https:\/\/doi.org\/10.1111\/ijpo.12601.","journal-title":"Pediatr Obes."},{"issue":"3\u20134","key":"1434_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000479868","volume":"88","author":"CS Hampe","year":"2017","unstructured":"Hampe CS, Shaffer ML, Roth CL. Associations between Liver Enzyme Levels and Parameters of the Metabolic Syndrome in Obese Children. Horm Res Paediatr. 2017;88(3\u20134):265\u201373. https:\/\/doi.org\/10.1159\/000479868.","journal-title":"Horm Res Paediatr"},{"issue":"9","key":"1434_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fendo.2018.00187","volume":"2","author":"D Corica","year":"2018","unstructured":"Corica D, Aversa T, Valenzise M, Messina MF, Alibrandi A, De Luca F, et al. Does Family History of Obesity, Cardiovascular, and Metabolic Diseases Influence Onset and Severity of Childhood Obesity? Front Endocrinol (Lausanne). 2018;2(9):187. https:\/\/doi.org\/10.3389\/fendo.2018.00187.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"1434_CR36","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2337\/dc07-1088","volume":"30","author":"AM Cali","year":"2007","unstructured":"Cali AM, Zern TL, Taksali SE, de Oliveira AM, Dufour S, Otvos JD, et al. Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care. 2007;30(12):3093\u20138. https:\/\/doi.org\/10.2337\/dc07-1088.","journal-title":"Diabetes Care"},{"issue":"8","key":"1434_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/10641963.2016.1200608","volume":"38","author":"X Hong","year":"2016","unstructured":"Hong X, Wongtongkam N, Ward PR, Xiao S, Wang S, Peng Q, et al. An association of serum ALT with elevated blood pressure in senior adults: a case-control study. Clin Exp Hypertens. 2016;38(8):691\u20135. https:\/\/doi.org\/10.1080\/10641963.2016.1200608.","journal-title":"Clin Exp Hypertens"},{"issue":"6","key":"1434_CR38","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/hep.23593","volume":"51","author":"EK Speliotes","year":"2010","unstructured":"Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010;51(6):1979\u201387. https:\/\/doi.org\/10.1002\/hep.23593.","journal-title":"Hepatology"},{"issue":"3","key":"1434_CR39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/HJH.0000000000000445","volume":"33","author":"S Patel","year":"2015","unstructured":"Patel S, Lawlor DA, Ferreira DL, Hughes AD, Chaturvedi N, Callaway M, et al. The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study. J Hypertens. 2015;33(3):546\u201352. https:\/\/doi.org\/10.1097\/HJH.0000000000000445.","journal-title":"J Hypertens"},{"issue":"11","key":"1434_CR40","doi-asserted-by":"publisher","first-page":"e112569","DOI":"10.1371\/journal.pone.0112569","volume":"9","author":"JB Schwimmer","year":"2014","unstructured":"Schwimmer JB, Zepeda A, Newton KP, Xanthakos SA, Behling C, Hallinan EK, et al. Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease. Nonalcoholic Steatohepatitis Clinical Research Network. PLoS One. 2014;9(11):e112569. https:\/\/doi.org\/10.1371\/journal.pone.0112569. (eCollection 2014).","journal-title":"PLoS One."},{"issue":"6","key":"1434_CR41","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1002\/hep.22858","volume":"49","author":"AM Cali","year":"2009","unstructured":"Cali AM, De Oliveira AM, Kim H, Chen S, Reyes-Mugica M, Escalera S, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology. 2009;49(6):1896\u2013903. https:\/\/doi.org\/10.1002\/hep.22858.","journal-title":"Hepatology"},{"key":"1434_CR42","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00125-016-3898-3","volume":"59","author":"TH Meek","year":"2016","unstructured":"Meek TH, Morton GJ. The role of leptin in diabetes: metabolic effects. Diabetologia. 2016;59:928\u201332. https:\/\/doi.org\/10.1007\/s00125-016-3898-3.","journal-title":"Diabetologia"},{"key":"1434_CR43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00535-007-2060-x","volume":"42","author":"M Yoneda","year":"2007","unstructured":"Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol. 2007;42:573\u201382. https:\/\/doi.org\/10.1007\/s00535-007-2060-x.","journal-title":"J Gastroenterol"},{"issue":"10","key":"1434_CR44","doi-asserted-by":"publisher","first-page":"e12835","DOI":"10.1111\/ijpo.12835","volume":"16","author":"A Gawlik","year":"2021","unstructured":"Gawlik A, Salonen A, Jian C, Yanover C, Antosz A, Shmoish M, Wasniewska M, Bereket A, Wudy SA, Hartmann MF, Thivel D, Matusik P, Weghuber D, Hochberg Z. Personalized approach to childhood obesity: Lessons from gut microbiota and omics studies. Narrative review and insights from the 29th European childhood obesity congress. Pediatr Obes. 2021;16(10):e12835. https:\/\/doi.org\/10.1111\/ijpo.12835.","journal-title":"Pediatr Obes."},{"key":"1434_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5604\/01.3001.0011.7380","volume":"17","author":"M Utz-Melere","year":"2018","unstructured":"Utz-Melere M, Targa-Ferreira C, Lessa-Horta B, Epifanio M, Mouzaki M, Mattos AA. Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change: a Systematic Review and Meta-Analysis. Ann Hepatol. 2018;17:345\u201354. https:\/\/doi.org\/10.5604\/01.3001.0011.7380.","journal-title":"Ann Hepatol"},{"key":"1434_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/hep.21262","volume":"44","author":"V Nobili","year":"2006","unstructured":"Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 2006;44:458\u201365. https:\/\/doi.org\/10.1002\/hep.21262.","journal-title":"Hepatology"},{"issue":"2","key":"1434_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MPG.0b013e31822cdedf","volume":"54","author":"H Gr\u00f8nb\u00e6k","year":"2012","unstructured":"Gr\u00f8nb\u00e6k H, Lange A, Birkeb\u00e6k NH, Holland Fischer P, Solvig J, H\u00f8rlyck A, et al. Effect of a10-week weigt los camp on fatty liver disease and insulin sensitivity in obese Danish children. J Pediatr Gastroenterol Nutr. 2012;54(2):223\u20138. https:\/\/doi.org\/10.1097\/MPG.0b013e31822cdedf.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"16","key":"1434_CR48","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","volume":"305","author":"JE Lavine","year":"2011","unstructured":"Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305(16):1659\u201368. https:\/\/doi.org\/10.1001\/jama.2011.520.","journal-title":"JAMA."},{"issue":"6","key":"1434_CR49","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1053\/j.gastro.2013.08.036","volume":"145","author":"MS Siddiqui","year":"2013","unstructured":"Siddiqui MS, Sterling RK, Luketic VA, Puri P, Stravitz RT, Bouneva I, Boyett S, Fuchs M, Sargeant C, Warnick GR, Grami S, Sanyal AJ. Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. Gastroenterology. 2013;145(6):1271-9.e1-3. https:\/\/doi.org\/10.1053\/j.gastro.2013.08.036.","journal-title":"Gastroenterology."}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01434-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-023-01434-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01434-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:15:54Z","timestamp":1679861754000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-023-01434-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1186\/s13052-023-01434-7","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol complied with Helsinki Declaration Guidelines and was approved by the Research and Ethics Commission, North Sanitary Area of Cordoba, Valle de los Pedroches Hospital, C\u00f3rdoba, Spain. All the parents or caregivers of the children included in this study gave their written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}